Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

Blood samples to help select the right early phase clinical trials for cancer patients

Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines

News digest – red and processed meat, DNA ‘fingerprints’, targeted leukaemia drugs and CRISPR

In the news this week: even moderation consumption of red and processed meat can increase bowel cancer risk.

Gene editing uncovers potential drug targets for aggressive brain tumours

Potential new drug targets for an aggressive type of brain tumour have been uncovered in the lab, thanks to a ‘reverse engineering’ approach using DNA editing.

Science Surgery: ‘How do tumours ‘know’ where to spread?’

It's hard to talking about cancers 'knowing' something, but they can have predictable patterns of spread. And scientists are beginning to understand why.

Even moderate red and processed meat eaters at risk of bowel cancer

People who eat red and processed meat within department of health guidelines are still at increased risk of bowel cancer, a Cancer Research UK study* has found.

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

News digest – cancer ‘vaccine factories’, cataloguing DNA weaknesses, NHS drug decisions and cancer sniffing canines

In this week’s news: scientists use CRISPR to catalogue cancer’s weaknesses and researchers train cancer sniffing canines.

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

Scientists use DNA-editing tool CRISPR to catalogue cancer’s weaknesses

UK scientists are putting together a list of the most promising potential cancer drug targets in one of the largest lab studies of its kind.

Breast cancer drug combo gets initial ‘no’ for NHS in England

Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.

Pages